Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sonoma Bioventures
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Sonoma Bioventures is a biotechnology investment and advisory firm founded in 2022 by industry veteran Casey Lynch. The firm provides strategic guidance, operational expertise, and capital to emerging life science companies, with a specialized focus on the development of treatments for neurological disorders. Leveraging the extensive experience of its leadership in founding and scaling biotech entities like Cortexyme and Lighthouse Pharmaceuticals, Sonoma Bioventures supports innovation across the neuropharmaceutical landscape. The firm is based in the San Francisco Bay Area and actively engages with the biotech community through board memberships and advisory roles.
- Industry
- Investors
Beyond the preview
Go deeper on Sonoma Bioventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sonoma Bioventures.